Financial News
SciSparc Ltd. - Ordinary Shares (NQ: SPRC )
0.6700
+0.0270
(+4.20%)
Streaming Delayed Price
Updated: 2:50 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about SciSparc Ltd. - Ordinary Shares
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/psychedelic-chemistry-geralt-by-pixabay_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/psychpatents.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/fractal-1680252-1280.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/13/scisparc_stock_sprc_shares_ai-generated-8245187_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/20/fluor_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Psyched-New---option-1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/24/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/24/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/cannabis-pharmaceutical-pot-stock.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/24/image23.jpeg?width=1200&height=800&fit=crop)
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales
January 24, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
From SciSparc Ltd
Via GlobeNewswire
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2023/12/cmnd1600-1024x576.png)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/13/image15_0.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
December 13, 2023
From SciSparc Ltd
Via GlobeNewswire
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2023/12/cmnd1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/04/psyched.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
SciSparc Adopts Limited Duration Shareholder Rights Plan
November 28, 2023
From SciSparc Ltd
Via GlobeNewswire
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.